Who Paid My Doc
Vueway (gadopiclenol)
Drug Diagnostic Imaging
General payments
$79,475
Research payments
$329,245
Through program year 2025, $79,475 in general payments and $329,245 in research payments were reported against Vueway (gadopiclenol) (Diagnostic Imaging).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
4 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $12,574 | 45 |
| 2025 | Research | $178,862 | 8 |
| 2024 | General | $66,901 | 38 |
| 2024 | Research | $150,383 | 10 |
Breakdown
The top 5 of 41 recipients; each share is of general payments naming this product in 2025.
The top 5 of 10 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 20 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
83 general · 18 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.